Gyre Therapeutics, Inc.
Nasdaq · Healthcare · Pharmaceutical Preparations · San Diego, CA
GYRE chart
What traders are saying about $GYRE
Latest postsGyre Therapeutics, Inc. news
- Understanding Momentum Shifts in (GYRE)
Stock Traders Daily ·
- Gyre Therapeutics, Inc. Estimates – NASDAQ:GYRE
TradingView ·
- Gyre Therapeutics - Enters Employment Agreement With Ying Luo As CEO - SEC Filing
TradingView ·
- Gyre Therapeutics signs new employment agreements with CEO Ying Luo and CFO Thomas Eastling
TradingView ·
- Gyre Therapeutics to Participate in Upcoming September Investor Conferences
Yahoo Finance ·
- Gyre Therapeutics, Inc. (GYRE) Reports Q2 Loss, Beats Revenue Estimates
Yahoo Finance ·
- Gyre Therapeutics Reports Second Quarter 2026 and Year-to-Date Financial Results and Provides Business Update
Yahoo Finance ·
- Gyre Therapeutics Appoints Three New Members to its Board of Directors
Yahoo Finance ·
- Gyre Therapeutics Announces NMPA Acceptance of New Drug Application for F351 (hydronidone) for CHB-Induced Liver Fibrosis Treatment
Yahoo Finance ·
- Gyre Therapeutics, Inc. (GYRE) Reports Q1 Loss, Lags Revenue Estimates
Yahoo Finance ·
- Gyre Therapeutics Reports First Quarter 2026 Results and Provides Business Update
Yahoo Finance ·
- US High Growth Tech Stocks To Watch
Yahoo Finance ·
Gyre Therapeutics, Inc. key financials
| USD | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Revenue | $116.6M | $105.8M | $113.5M | $102.3M |
| Net income | $9.9M | $17.9M | -$85.5M | $4.3M |
| Diluted EPS | $0.02 | $0.05 | $-1.41 | $0.03 |
| Total assets (year end) | $219.8M | $125.4M | $116.5M | $84.8M |
| Cash and equivalents (year end) | $49.2M | $11.8M | $33.5M | $25.2M |
Calendar-year figures as reported to the SEC in XBRL filings.
Recent SEC filings
About Gyre Therapeutics, Inc.
- Ticker
- GYRE (Nasdaq)
- Industry
- Pharmaceutical Preparations
- Headquarters
- San Diego, CA
- Incorporated in
- DE
- Fiscal year end
- December 31
- SEC CIK
- 1124105
- Former names
- CATALYST BIOSCIENCES, INC., TARGACEPT INC
Frequently asked questions
What exchange is Gyre Therapeutics, Inc. listed on?
Gyre Therapeutics, Inc. trades on the Nasdaq under the ticker symbol GYRE.
What industry is Gyre Therapeutics, Inc. in?
Gyre Therapeutics, Inc. is classified by the SEC under "Pharmaceutical Preparations", part of the Healthcare sector on StockTweeting.
Where is Gyre Therapeutics, Inc. headquartered?
Gyre Therapeutics, Inc.'s business address on file with the SEC is in San Diego, CA.
When does Gyre Therapeutics, Inc.'s fiscal year end?
Gyre Therapeutics, Inc.'s fiscal year ends on December 31.
How much revenue did Gyre Therapeutics, Inc. report?
Gyre Therapeutics, Inc. reported $116.6M in revenue for calendar year 2025, according to its SEC filings.